---
$id: https://graph.org.ai/products/commodity/51111665
$type: Product
source: UNSPSC
code: "51111665"
title: "Thioguanine or tioguanine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Thioguanine or tioguanine

**UNSPSC Code**: 51111665
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and amidophosphoribosyltransferase inhibitor with the molecular formula C5H5N5S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FTK8U1GZNX, chemically known as 6h-purine-6-thione, 2-amino-1,7-dihydro- but generally known as thioguanine, which bears US NIH Compound Identifier 2723601. European Medicines Agency schedules Tioguanine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11084MIG. World Health Organization schedules thioguanine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, THIOGUANINE remains the US FDA Preferred Term for this commodity. Thioguanine bears US NLM identifiers UMLS ID C0039902 and NCI Concept Code C876. SMILES: S=C1NC([NH]C2NC[NH]C12)N.

